All data are based on the daily closing price as of December 24, 2024
b
Boryung
003850.KO
7.15 USD
0.11
+1.56%
Overview
Last close
7.15 usd
Market cap
600.73M usd
52 week high
10.04 usd
52 week low
5.95 usd
Target price
10.28 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
0.933
Price/Book Value
1.4324
Enterprise Value
696.33M usd
EV/Revenue
1.0248
EV/EBITDA
9.327
Key financials
Revenue TTM
636.47M usd
Gross Profit TTM
210.52M usd
EBITDA TTM
77.34M usd
Earnings per Share
N/A usd
Dividend
0.07 usd
Total assets
1,029.65B usd
Net debt
N/A usd
About
Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.